New Warnings about Tequin (gatifloxacin)

May 19, 2006 - Bristol-Myers Squibb has decided to discontinue the commercialization of Tequin (gatifloxacin) tablets and injection. They have decided to cease shipping the product to wholesalers in the United States effective June 2, 2006.

Drug Shortage: Tequin (gatifloxacin) tablets and injection

NDC #s: 0015-1180-78, 0015-1180-79, 0015-1181-78, 0015-1181-79, 0015-1179-80, 0015-1177-80, 0015-1117-80, 0015-1117-50, 0015-1117-60, and 0015-1117-21

Manufacturer: Bristol-Myers Squibb (609-897-2000)

Reason for Shortage: Drug to be discontinued.

Additional Information: Tequin is an antibiotic of the fluoroquinolone class. Alternative antibiotics are available for future courses of treatment.

More information can be found on the Bristol-Myers Squibb Co website at www.bms.com.

As always, pharmacies and members can also contact the RxAmerica customer service desk at 1-800-770-8014 if they have any questions about this new product warning.